*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. This morning, 1 April 2008, Advocate General Dámaso Ruiz-Jarabo Colomer stated delivered its Opinion in Cases C-468/06 to C-478/06 (Sot. Lélos Kai Sia E.E and others against GlaxoSmithKline AEVE Farmakeftikon Proїonton) concerning the prohibition imposed by the pharmaceutical company Glaxosmithkline to its Greek wholesalers to carry out imports parallel trade in certain medicinal products to other Member States, where the reimbursement of prices paid for drugs dispensed on medical prescription is significantly higher than that practiced in Greece. The Court of Justice is therefore once again before the Court of Justice, this time by a true jurisdiction - the
ALERTS : UNILATERAL PRACTICES - ABUSE OF DOMINANCE - PARALLEL TRADE - MEDECINE - JUSTIFICATIONS - OPINION
Parallel trade: ECJ Advocate General Dámas o Ruiz-Jarabo Colomer presents his opinion in the case related to the parallel trade of medecine performed by Greek wholesalers (Lélos kai Sia / GSK)
Access to this article is restricted to subscribers
Already Subscribed? Sign-in
Access to this article is restricted to subscribers.
Read one article for free
Sign-up to read this article for free and discover our services.